IL-5 synthesis by T cells of allergic subjects is regulated at the transcriptional level

Int Arch Allergy Immunol. 2000 May:122 Suppl 1:63-6. doi: 10.1159/000053636.

Abstract

Background: IL-5 plays a central role in allergic diseases associated with eosinophilic inflammation. We have previously reported that IL-5 production by peripheral blood mononuclear cells (PBMC) is greatly enhanced in both atopic and nonatopic asthmatics compared to control subjects.

Method: Concanavalin A (Con A) blast lymphocytes were derived from PBMC of allergic and control subjects. Transcriptional regulation of the IL-5 gene was investigated by transient transfection assay.

Results: A significant amount of IL-5 was produced by Con A blast lymphocytes derived from allergic subjects upon stimulation with phorbol ester and Ca(2+) ionophore, whereas the cells derived from control subjects did not produce a detectable amount of IL-5. Production of IL-2 and IL-4 was not significantly different between the two groups. A luciferase reporter plasmid containing the human IL-5 promoter/enhancer region was transcribed by Con A blast lymphocytes derived from allergic subjects, but not by the cells from control subjects, upon activation.

Conclusion: IL-5 synthesis by nontransformed T cells of allergic subjects is enhanced at the level of gene transcription. Elucidation of the molecular mechanism of IL-5 gene transcription by allergic T cells may delineate the pathogenesis of allergic disease for the future therapeutic intervention.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Concanavalin A / pharmacology
  • Humans
  • Hypersensitivity / immunology*
  • Interleukin-5 / biosynthesis*
  • Interleukin-5 / genetics
  • Middle Aged
  • T-Lymphocytes / metabolism*
  • Transcription, Genetic

Substances

  • Interleukin-5
  • Concanavalin A